Warren Buffett's Berkshire In Talks To Buy OxyChem For $10 Billion: Report

Berkshire Hathaway is reportedly in advanced talks to acquire Occidental Petroleum's chemical division, OxyChem, for approximately $10 billion. This potential deal, which would be Berkshire's largest since 2022, signifies a significant deployment of its record $344 billion cash reserves and would further deepen its ties with Occidental, where it is already the largest shareholder. For Occidental, the sale of its unit, which generated nearly $5 billion in revenue, would support its ongoing debt reduction efforts.

Analysis

Berkshire Hathaway is in advanced negotiations to acquire Occidental Petroleum's chemical division, OxyChem, for approximately $10 billion. This transaction represents a significant strategic move for both entities, underscored by a strongly positive market sentiment. For Berkshire, this would be its largest acquisition since its $11.6 billion purchase of Alleghany in 2022 and marks a substantial deployment of its record $344 billion cash reserves. The deal signals a deepening of its commitment to Occidental, where it is already the largest shareholder with a 28% stake, and represents its second major investment in the chemical sector following the 2011 Lubrizol acquisition. For Occidental, the divestiture of this unit, which generated nearly $5 billion in revenue in the year ending June, is a critical component of its ongoing deleveraging strategy. The proceeds would accelerate the reduction of debt incurred from its $38 billion acquisition of Anadarko, a process that has already seen $7.5 billion repaid by August. This move aligns with CEO Vicki Hollub's efforts to streamline the company and strengthens the strategic partnership with Warren Buffett that began with the 2019 financing deal.

Key Decisions for Investors

• For Berkshire Hathaway shareholders, this potential acquisition should be viewed as a constructive use of its vast cash pile, deploying capital into a sizable industrial asset that complements its portfolio and is expected to be accretive to long-term earnings.
• Investors in Occidental Petroleum should see this as a significant credit-positive event that materially de-risks the balance sheet, validates the value of its non-core assets, and allows management to increase focus on its primary E&P operations.
• Monitor the final closing of the deal, as its successful execution at the reported valuation would solidify the strategic alignment and underscore Buffett's conviction in Occidental's assets, while any failure to complete the transaction could introduce uncertainty for OXY's deleveraging timeline.